Valuation: AngioDynamics, Inc.

Market Cap 458M 409M 382M 346M 651M 43.51B 656M 4.57B 1.79B 22.63B 1.72B 1.68B 72.62B P/E 2027 *
-16x
P/E 2028 * -31.1x
Enterprise Value 458M 409M 382M 346M 651M 43.51B 656M 4.57B 1.79B 22.63B 1.72B 1.68B 72.62B EV / Sales 2027 *
1.36x
EV / Sales 2028 * 1.29x
Free-Float
85.66%
Yield 2027 *
-
Yield 2028 * -
1 day-4.39%
1 week-24.41%
Current month-29.13%
1 month-28.62%
3 months-14.68%
6 months+6.45%
Current year-15.11%
1 week 10.62
Extreme 10.62
13.8
1 month 10.62
Extreme 10.62
15.92
Current year 9.39
Extreme 9.39
16.29
1 year 9.39
Extreme 9.39
16.29
3 years 5.26
Extreme 5.26
16.29
5 years 5.26
Extreme 5.26
32
10 years 5.26
Extreme 5.26
32
Manager TitleAgeSince
Chief Executive Officer 62 2016-03-31
Director of Finance/CFO 51 2019-10-22
Chief Tech/Sci/R&D Officer - 2016-12-31
Director TitleAgeSince
Chairman 65 2014-04-28
Director/Board Member 68 2007-01-28
Director/Board Member 62 2016-03-31
Date Insider Type Main position Quantity % Market Cap. Importance
7/30/26 Sell

General Counsel

-23,370 0.0565%
7/22/26 Exercice

Executive/Senior Manager

40,889 0.0990%
7/22/26 Exercice

General Counsel

27,417 0.0664%
Change 5-day change 1-year change 3-year change Capi.($)
-4.39%-24.41%-2.07%+65.91% 479M
+0.78%+4.53%-21.90%+12.92% 176B
+1.17%+6.80%-2.69%+29.25% 118B
-0.02%+1.56%-22.57%+9.57% 108B
-0.31%-0.27%-46.72%-10.85% 75.34B
+1.55%+4.34%+4.14%+74.68% 62.03B
+0.12%+0.86%+19.52%+66.67% 52.8B
-0.80%+3.92%+0.38%-27.57% 51.45B
-0.69%+0.95%-17.84%+22.09% 41.28B
-0.17%+0.42% - - 31.37B
Average -0.27%+0.03%-9.97%+26.96% 71.69B
Weighted average by Cap. +0.38%+3.32%-13.96%+19.86%

Financials

2027 *2028 *
Net sales 338M 302M 281M 255M 480M 32.06B 484M 3.37B 1.32B 16.67B 1.27B 1.24B 53.5B 355M 317M 296M 268M 504M 33.69B 508M 3.54B 1.39B 17.52B 1.33B 1.3B 56.22B
Net income -27.1M -24.21M -22.56M -20.46M -38.5M -2.57B -38.8M -270M -106M -1.34B -102M -99.54M -4.29B -18.19M -16.25M -15.15M -13.73M -25.84M -1.73B -26.05M -181M -71.04M -898M -68.32M -66.82M -2.88B
Net Debt - -
Projected Income Statement - Annual - AngioDynamics, Inc.
Logo AngioDynamics, Inc.
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.
Employees
632
Date Price Change Volume
26-10-13 US$10.90 -4.39% 1,345,975
26-10-12 US$11.40 -1.04% 1,083,166
26-10-09 US$11.52 +2.58% 2,156,139
26-10-08 US$11.23 -20.86% 3,065,522
26-10-07 US$14.19 -1.60% 1,012,599
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - AngioDynamics, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
10.90USD
Average target price
19.75USD
Spread / Average Target
+81.19%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - AngioDynamics, Inc.
  1. Stock Market
  2. Stocks
  3. ANGO Stock